“We intend to change the face of brain diseases like Alzheimer’s, dementia, and ALS as we bring hope and healing to those who have for too long lived with neither.”
ABOUT MARY KAY ROSS, M.D., FACEP
Following an extensive career in trauma medicine, Dr. Ross served as the Chief Medical Officer of MPI Cognition, the firm credited with introducing multi-modal Alzheimer’s therapies to America.
While at MPI Cognition, Ross trained hundreds of physicians and helped to improve brain health and cognition for thousands of patients.
Since 2010, Ross has owned and operated The Institute for Personalized Medicine, at which she established her leadership in the study of molds, toxins, fungi, and heavy metals as contributors to Alzheimer’s and other brain diseases.
As founder of the Brain Health & Research Institute, Dr. Ross currently leads the team of medical practitioners trained in the administration of multi-modal therapies that have demonstrated early clinical promise in the detection, slowing, and in some cases, reversal of neurodegenerative cases.
The Brain Health & Research Institute is a revolutionary enterprise dedicated to the evaluation, prevention, and treatment of neurodegenerative diseases, including Alzheimer’s, dementia, and ALS, among others.